Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

OBJECTIVE: In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of lipoprotein(a) influences incident type 2 diabetes is unknown. We determined the relationship of lipoprotein(a) concentration with incid...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Gregory G., Szarek, Michael, Bittner, Vera A., Bhatt, Deepak L., Diaz, Rafael, Goodman, Shaun G., Jukema, J. Wouter, Loy, Megan, Manvelian, Garen, Pordy, Robert, White, Harvey D., Steg, Philippe Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132323/
https://www.ncbi.nlm.nih.gov/pubmed/33722880
http://dx.doi.org/10.2337/dc20-2842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132323/
https://www.ncbi.nlm.nih.gov/pubmed/33722880
http://dx.doi.org/10.2337/dc20-2842

Ejemplares similares